Jordan Hospital holds the second conference on aortic valve transplantation...
The second conference on transcatheter aortic valve implantation (TAVI) was held at Jordan Hospital at the end of last March. The conference was chaired by Dr. Imad Al-Haddad, and was attended by over 400,000 participants from America, Europe, and the Middle East.
During the conference, the treatment of aortic valves using modern therapeutic catheters, without surgery for special and complex cases, was discussed. This is considered one of the most modern treatment methods in the world.
The conference participants reviewed this remarkable development in the field of cardiology and the qualitative leap in technology in Jordan, which in turn facilitates rapid and accurate diagnosis of aortic valve disease patients and, consequently, treatment using the latest therapeutic catheterization techniques.
Dr. Al Haddad pointed out that Jordan Hospital was the first in the region to implement this procedure, having performed valve implants on many patients in complex cases.
For their part, the participants praised the distinguished level of the two Jordanian hospitals in this regard. They expressed their cooperation and desire to continue the dialogue, enhance medical capabilities, and increase the sharing of medical successes.
It’s worth noting that Cardiovascular Diseases and Interventional Medicine Consultant Dr. Imad Al-Haddad has achieved a global medical breakthrough by implanting a mitral valve (the most complex and difficult heart valve) using a therapeutic catheter without surgery, lasting two hours.
Dr. Haddad said the patient, in his eighties, had undergone open-heart surgery and an animal valve implant in 2004. He had begun to suffer from heart failure and muscle weakness due to a damaged and torn mitral valve, which led to difficulty breathing and movement.
He pointed out that based on the patient’s condition, a fully integrated Jordanian medical team with high competencies was formed. He pointed out that the operation was performed using therapeutic catheterization technology, whereby the valve was inserted through the femoral vein into the right atrium of the heart and then moved to the left atrium by creating a small hole between the atria. After that, the valve was inserted into its location and implanted with extreme precision and complete success.
The doctor continued that the patient returned to normal health after the operation, was able to move around within a few hours of the valve implantation, and his previous symptoms subsided. He was discharged from the hospital two days later.
Dr. Imad Al-Haddad, who achieved one of the most important unprecedented accomplishments in 2009, when he was able to implant an aortic valve via therapeutic catheterization, at that time a qualitative leap in his field, confirmed:
He pointed out that the development of therapeutic catheterization in valve implantation now includes the mitral valve, opening the doors of hope and recovery opportunities for heart valve patients.
Dr. Imad Al-Haddad
Consultant in Cardiovascular Surgery and Therapeutic Interventions
The interview was conducted by: Manar Zawahra
Amman
